Jove
Visualize
Contact Us

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Urinary Tract Infection IV: Nursing Management01:17

Urinary Tract Infection IV: Nursing Management

In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs like...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epidemiology and Clinical Characteristics of Ocular Tuberculosis in the United States, 1993-2019.

Open forum infectious diseases·2024
Same author

Malignant Fungating Wounds of the Head and Neck: Management and Antibiotic Stewardship.

OTO open·2022
Same author

Evaluation of <i>Escherichia coli</i> resistance to fluoroquinolones in men undergoing prostate procedures: Is it time to change preoperative prophylaxis?

Infection control and hospital epidemiology·2021
Same author

Safe at First, But Not Reaching Second: Implications of Delayed Second Doses of Antimicrobials in Patients Presenting to Emergency Departments With Sepsis.

Critical care medicine·2017
Same author

A Tale of Two Ticking Clocks: Time to Administration of Appropriate Antibiotics and Time to Acquisition of Antimicrobial Resistant Pathogens.

Critical care medicine·2016
Same author

Risk of Clostridium difficile infection in intensive care unit patients with sepsis exposed to metronidazole.

Infectious diseases (London, England)·2015
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systemic antimicrobial therapy in osteomyelitis.

Henry S Fraimow1

  • 1University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Division of Infectious Diseases, Cooper University Hospital, Camden, New Jersey.

Seminars in Plastic Surgery
|June 23, 2010
PubMed
Summary

Effective antibiotic treatment for osteomyelitis depends on drug spectrum, not just route. Newer agents offer options for resistant bacteria, but evidence remains limited, relying on expert opinion.

Keywords:
OsteomyelitisStaphylococcus aureus osteomyelitisfluoroquinolonesmethicillin-resistant Staphylococcus aureusoutpatient parenteral antibiotic therapy

Related Experiment Videos

Area of Science:

  • Infectious Diseases
  • Orthopedic Surgery
  • Pharmacology

Background:

  • Antibiotic regimens are crucial for managing osteomyelitis, with varying goals across infection stages.
  • Antibiotic selection prioritizes spectrum of action, with achievable drug levels at the infection site being more critical than administration route.
  • Current recommendations often rely on expert opinion and limited studies due to a lack of high-quality comparative trials.

Purpose of the Study:

  • To review current strategies and considerations for antibiotic therapy in osteomyelitis.
  • To highlight the importance of antibiotic spectrum and achievable drug levels in treatment efficacy.
  • To discuss available and emerging antibiotic options for various causative pathogens, including resistant strains.

Main Methods:

  • Review of existing literature, including case series and animal models.
  • Analysis of expert opinions and clinical guidelines for osteomyelitis management.
  • Evaluation of antibiotic properties, such as spectrum of action and route of administration.

Main Results:

  • Intravenous beta-lactams are preferred for methicillin-susceptible Staphylococcus aureus (MSSA), with oral alternatives available.
  • Vancomycin has been standard for methicillin-resistant Staphylococcus aureus (MRSA), but newer agents like linezolid and daptomycin are emerging.
  • Rifampin combination therapy may improve outcomes, particularly for device-associated infections. Fluoroquinolones and beta-lactams are options for gram-negative osteomyelitis, though resistance is a growing concern.

Conclusions:

  • Optimizing antibiotic regimens requires careful consideration of drug spectrum and achievable concentrations.
  • While outpatient parenteral and oral therapies have improved treatment delivery, robust comparative data is scarce.
  • Management of resistant pathogens like MRSA and gram-negative bacteria necessitates exploring newer agents and combination therapies.